KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) Shareholder Alert: Lawsuit Alleges Misleading Statements
A shareholder in KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by KaloBios Pharmaceuticals Inc.
View full press release